Global Latent Tuberculosis Infection (LTBI) Testing Market Growth (Status and Outlook) 2022-2028
As the global economy mends, the 2021 growth of Latent Tuberculosis Infection (LTBI) Testing will have significant change from previous year. According to our latest study, the global Latent Tuberculosis Infection (LTBI) Testing market size is USD million in 2022 from USD 1365.6 million in 2021, with a change of % between 2021 and 2022. The global Latent Tuberculosis Infection (LTBI) Testing market size will reach USD 2000 million in 2028, growing at a CAGR of 5.6% over the analysis period.
The United States Latent Tuberculosis Infection (LTBI) Testing market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Latent Tuberculosis Infection (LTBI) Testing market, reaching US$ million by the year 2028. As for the Europe Latent Tuberculosis Infection (LTBI) Testing landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Latent Tuberculosis Infection (LTBI) Testing players cover Qiagen, Sanofi, Oxford Immunotec, and Thermo Fisher Scientific, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Latent Tuberculosis Infection (LTBI) Testing market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals and Clinics
Diagnostic Laboratories
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Qiagen
Sanofi
Oxford Immunotec
Thermo Fisher Scientific
Par Sterile
Bio-Rad Laboratories
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Latent Tuberculosis Infection (LTBI) Testing Market Size 2017-2028
2.1.2 Latent Tuberculosis Infection (LTBI) Testing Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Latent Tuberculosis Infection (LTBI) Testing Segment by Type
2.2.1 Tuberculin Skin Test (TST)
2.2.2 Interferon Gamma Released Assay (IGRA)
2.3 Latent Tuberculosis Infection (LTBI) Testing Market Size by Type
2.3.1 Latent Tuberculosis Infection (LTBI) Testing Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Type (2017-2022)
2.4 Latent Tuberculosis Infection (LTBI) Testing Segment by Application
2.4.1 Hospitals and Clinics
2.4.2 Diagnostic Laboratories
2.4.3 Others
2.5 Latent Tuberculosis Infection (LTBI) Testing Market Size by Application
2.5.1 Latent Tuberculosis Infection (LTBI) Testing Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Application (2017-2022)
3 Latent Tuberculosis Infection (LTBI) Testing Market Size by Player
3.1 Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Players
3.1.1 Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Players (2020-2022)
3.1.2 Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Players (2020-2022)
3.2 Global Latent Tuberculosis Infection (LTBI) Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Latent Tuberculosis Infection (LTBI) Testing by Regions
4.1 Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions (2017-2022)
4.2 Americas Latent Tuberculosis Infection (LTBI) Testing Market Size Growth (2017-2022)
4.3 APAC Latent Tuberculosis Infection (LTBI) Testing Market Size Growth (2017-2022)
4.4 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Growth (2017-2022)
4.5 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Growth (2017-2022)
5 Americas
5.1 Americas Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2017-2022)
5.2 Americas Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2017-2022)
5.3 Americas Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2017-2022)
6.2 APAC Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2017-2022)
6.3 APAC Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Latent Tuberculosis Infection (LTBI) Testing by Country (2017-2022)
7.2 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2017-2022)
7.3 Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing by Region (2017-2022)
8.2 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2017-2022)
8.3 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Latent Tuberculosis Infection (LTBI) Testing Market Forecast
10.1 Global Latent Tuberculosis Infection (LTBI) Testing Forecast by Regions (2023-2028)
10.1.1 Global Latent Tuberculosis Infection (LTBI) Testing Forecast by Regions (2023-2028)
10.1.2 Americas Latent Tuberculosis Infection (LTBI) Testing Forecast
10.1.3 APAC Latent Tuberculosis Infection (LTBI) Testing Forecast
10.1.4 Europe Latent Tuberculosis Infection (LTBI) Testing Forecast
10.1.5 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Forecast
10.2 Americas Latent Tuberculosis Infection (LTBI) Testing Forecast by Country (2023-2028)
10.2.1 United States Latent Tuberculosis Infection (LTBI) Testing Market Forecast
10.2.2 Canada Latent Tuberculosis Infection (LTBI) Testing Market Forecast
10.2.3 Mexico Latent Tuberculosis Infection (LTBI) Testing Market Forecast
10.2.4 Brazil Latent Tuberculosis Infection (LTBI) Testing Market Forecast
10.3 APAC Latent Tuberculosis Infection (LTBI) Testing Forecast by Region (2023-2028)
10.3.1 China Latent Tuberculosis Infection (LTBI) Testing Market Forecast
10.3.2 Japan Latent Tuberculosis Infection (LTBI) Testing Market Forecast
10.3.3 Korea Latent Tuberculosis Infection (LTBI) Testing Market Forecast
10.3.4 Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Forecast
10.3.5 India Latent Tuberculosis Infection (LTBI) Testing Market Forecast
10.3.6 Australia Latent Tuberculosis Infection (LTBI) Testing Market Forecast
10.4 Europe Latent Tuberculosis Infection (LTBI) Testing Forecast by Country (2023-2028)
10.4.1 Germany Latent Tuberculosis Infection (LTBI) Testing Market Forecast
10.4.2 France Latent Tuberculosis Infection (LTBI) Testing Market Forecast
10.4.3 UK Latent Tuberculosis Infection (LTBI) Testing Market Forecast
10.4.4 Italy Latent Tuberculosis Infection (LTBI) Testing Market Forecast
10.4.5 Russia Latent Tuberculosis Infection (LTBI) Testing Market Forecast
10.5 Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Forecast by Region (2023-2028)
10.5.1 Egypt Latent Tuberculosis Infection (LTBI) Testing Market Forecast
10.5.2 South Africa Latent Tuberculosis Infection (LTBI) Testing Market Forecast
10.5.3 Israel Latent Tuberculosis Infection (LTBI) Testing Market Forecast
10.5.4 Turkey Latent Tuberculosis Infection (LTBI) Testing Market Forecast
10.5.5 GCC Countries Latent Tuberculosis Infection (LTBI) Testing Market Forecast
10.6 Global Latent Tuberculosis Infection (LTBI) Testing Forecast by Type (2023-2028)
10.7 Global Latent Tuberculosis Infection (LTBI) Testing Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Qiagen
11.1.1 Qiagen Company Information
11.1.2 Qiagen Latent Tuberculosis Infection (LTBI) Testing Product Offered
11.1.3 Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Qiagen Main Business Overview
11.1.5 Qiagen Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Latent Tuberculosis Infection (LTBI) Testing Product Offered
11.2.3 Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Oxford Immunotec
11.3.1 Oxford Immunotec Company Information
11.3.2 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product Offered
11.3.3 Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Oxford Immunotec Main Business Overview
11.3.5 Oxford Immunotec Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product Offered
11.4.3 Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Par Sterile
11.5.1 Par Sterile Company Information
11.5.2 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product Offered
11.5.3 Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Par Sterile Main Business Overview
11.5.5 Par Sterile Latest Developments
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Information
11.6.2 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product Offered
11.6.3 Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Bio-Rad Laboratories Main Business Overview
11.6.5 Bio-Rad Laboratories Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Latent Tuberculosis Infection (LTBI) Testing Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Tuberculin Skin Test (TST)
Table 3. Major Players of Interferon Gamma Released Assay (IGRA)
Table 4. Latent Tuberculosis Infection (LTBI) Testing Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Type (2017-2022)
Table 7. Latent Tuberculosis Infection (LTBI) Testing Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Application (2017-2022)
Table 10. Global Latent Tuberculosis Infection (LTBI) Testing Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Player (2020-2022)
Table 12. Latent Tuberculosis Infection (LTBI) Testing Key Players Head office and Products Offered
Table 13. Latent Tuberculosis Infection (LTBI) Testing Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Latent Tuberculosis Infection (LTBI) Testing Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Regions (2017-2022)
Table 18. Americas Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Country (2017-2022)
Table 20. Americas Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Type (2017-2022)
Table 22. Americas Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Application (2017-2022)
Table 24. APAC Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Region (2017-2022)
Table 26. APAC Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Type (2017-2022)
Table 28. APAC Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Application (2017-2022)
Table 30. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Country (2017-2022)
Table 32. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Type (2017-2022)
Table 34. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Latent Tuberculosis Infection (LTBI) Testing
Table 43. Key Market Challenges & Risks of Latent Tuberculosis Infection (LTBI) Testing
Table 44. Key Industry Trends of Latent Tuberculosis Infection (LTBI) Testing
Table 45. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share Forecast by Application (2023-2028)
Table 51. Qiagen Details, Company Type, Latent Tuberculosis Infection (LTBI) Testing Area Served and Its Competitors
Table 52. Qiagen Latent Tuberculosis Infection (LTBI) Testing Product Offered
Table 53. Qiagen Latent Tuberculosis Infection (LTBI) Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Qiagen Main Business
Table 55. Qiagen Latest Developments
Table 56. Sanofi Details, Company Type, Latent Tuberculosis Infection (LTBI) Testing Area Served and Its Competitors
Table 57. Sanofi Latent Tuberculosis Infection (LTBI) Testing Product Offered
Table 58. Sanofi Main Business
Table 59. Sanofi Latent Tuberculosis Infection (LTBI) Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Sanofi Latest Developments
Table 61. Oxford Immunotec Details, Company Type, Latent Tuberculosis Infection (LTBI) Testing Area Served and Its Competitors
Table 62. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Product Offered
Table 63. Oxford Immunotec Main Business
Table 64. Oxford Immunotec Latent Tuberculosis Infection (LTBI) Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Oxford Immunotec Latest Developments
Table 66. Thermo Fisher Scientific Details, Company Type, Latent Tuberculosis Infection (LTBI) Testing Area Served and Its Competitors
Table 67. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Product Offered
Table 68. Thermo Fisher Scientific Main Business
Table 69. Thermo Fisher Scientific Latent Tuberculosis Infection (LTBI) Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Thermo Fisher Scientific Latest Developments
Table 71. Par Sterile Details, Company Type, Latent Tuberculosis Infection (LTBI) Testing Area Served and Its Competitors
Table 72. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Product Offered
Table 73. Par Sterile Main Business
Table 74. Par Sterile Latent Tuberculosis Infection (LTBI) Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Par Sterile Latest Developments
Table 76. Bio-Rad Laboratories Details, Company Type, Latent Tuberculosis Infection (LTBI) Testing Area Served and Its Competitors
Table 77. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Product Offered
Table 78. Bio-Rad Laboratories Main Business
Table 79. Bio-Rad Laboratories Latent Tuberculosis Infection (LTBI) Testing Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Bio-Rad Laboratories Latest Developments
List of Figures
Figure 1. Latent Tuberculosis Infection (LTBI) Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Type in 2021
Figure 7. Latent Tuberculosis Infection (LTBI) Testing in Hospitals and Clinics
Figure 8. Global Latent Tuberculosis Infection (LTBI) Testing Market: Hospitals and Clinics (2017-2022) & ($ Millions)
Figure 9. Latent Tuberculosis Infection (LTBI) Testing in Diagnostic Laboratories
Figure 10. Global Latent Tuberculosis Infection (LTBI) Testing Market: Diagnostic Laboratories (2017-2022) & ($ Millions)
Figure 11. Latent Tuberculosis Infection (LTBI) Testing in Others
Figure 12. Global Latent Tuberculosis Infection (LTBI) Testing Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Application in 2021
Figure 14. Global Latent Tuberculosis Infection (LTBI) Testing Revenue Market Share by Player in 2021
Figure 15. Global Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Latent Tuberculosis Infection (LTBI) Testing Market Size 2017-2022 ($ Millions)
Figure 17. APAC Latent Tuberculosis Infection (LTBI) Testing Market Size 2017-2022 ($ Millions)
Figure 18. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size 2017-2022 ($ Millions)
Figure 20. Americas Latent Tuberculosis Infection (LTBI) Testing Value Market Share by Country in 2021
Figure 21. Americas Latent Tuberculosis Infection (LTBI) Testing Consumption Market Share by Type in 2021
Figure 22. Americas Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Application in 2021
Figure 23. United States Latent Tuberculosis Infection (LTBI) Testing Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Latent Tuberculosis Infection (LTBI) Testing Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Latent Tuberculosis Infection (LTBI) Testing Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Latent Tuberculosis Infection (LTBI) Testing Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Region in 2021
Figure 28. APAC Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Application in 2021
Figure 29. China Latent Tuberculosis Infection (LTBI) Testing Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Latent Tuberculosis Infection (LTBI) Testing Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Latent Tuberculosis Infection (LTBI) Testing Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Latent Tuberculosis Infection (LTBI) Testing Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Latent Tuberculosis Infection (LTBI) Testing Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Country in 2021
Figure 36. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Type in 2021
Figure 37. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Application in 2021
Figure 38. Germany Latent Tuberculosis Infection (LTBI) Testing Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Latent Tuberculosis Infection (LTBI) Testing Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Latent Tuberculosis Infection (LTBI) Testing Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Latent Tuberculosis Infection (LTBI) Testing Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Latent Tuberculosis Infection (LTBI) Testing Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Market Share by Application in 2021
Figure 46. Egypt Latent Tuberculosis Infection (LTBI) Testing Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Latent Tuberculosis Infection (LTBI) Testing Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Latent Tuberculosis Infection (LTBI) Testing Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Latent Tuberculosis Infection (LTBI) Testing Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Latent Tuberculosis Infection (LTBI) Testing Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Latent Tuberculosis Infection (LTBI) Testing Market Size 2023-2028 ($ Millions)
Figure 52. APAC Latent Tuberculosis Infection (LTBI) Testing Market Size 2023-2028 ($ Millions)
Figure 53. Europe Latent Tuberculosis Infection (LTBI) Testing Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Latent Tuberculosis Infection (LTBI) Testing Market Size 2023-2028 ($ Millions)
Figure 55. United States Latent Tuberculosis Infection (LTBI) Testing Market Size 2023-2028 ($ Millions)
Figure 56. Canada Latent Tuberculosis Infection (LTBI) Testing Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Latent Tuberculosis Infection (LTBI) Testing Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Latent Tuberculosis Infection (LTBI) Testing Market Size 2023-2028 ($ Millions)
Figure 59. China Latent Tuberculosis Infection (LTBI) Testing Market Size 2023-2028 ($ Millions)
Figure 60. Japan Latent Tuberculosis Infection (LTBI) Testing Market Size 2023-2028 ($ Millions)
Figure 61. Korea Latent Tuberculosis Infection (LTBI) Testing Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Latent Tuberculosis Infection (LTBI) Testing Market Size 2023-2028 ($ Millions)
Figure 63. India Latent Tuberculosis Infection (LTBI) Testing Market Size 2023-2028 ($ Millions)
Figure 64. Australia Latent Tuberculosis Infection (LTBI) Testing Market Size 2023-2028 ($ Millions)
Figure 65. Germany Latent Tuberculosis Infection (LTBI) Testing Market Size 2023-2028 ($ Millions)
Figure 66. France Latent Tuberculosis Infection (LTBI) Testing Market Size 2023-2028 ($ Millions)
Figure 67. UK Latent Tuberculosis Infection (LTBI) Testing Market Size 2023-2028 ($ Millions)
Figure 68. Italy Latent Tuberculosis Infection (LTBI) Testing Market Size 2023-2028 ($ Millions)
Figure 69. Russia Latent Tuberculosis Infection (LTBI) Testing Market Size 2023-2028 ($ Millions)
Figure 70. Spain Latent Tuberculosis Infection (LTBI) Testing Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Latent Tuberculosis Infection (LTBI) Testing Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Latent Tuberculosis Infection (LTBI) Testing Market Size 2023-2028 ($ Millions)
Figure 73. Israel Latent Tuberculosis Infection (LTBI) Testing Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Latent Tuberculosis Infection (LTBI) Testing Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Latent Tuberculosis Infection (LTBI) Testing Market Size 2023-2028 ($ Millions)
